These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 17349883

  • 21. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.
    Lagerqvist B, James SK, Stenestrand U, Lindbäck J, Nilsson T, Wallentin L, SCAAR Study Group.
    N Engl J Med; 2007 Mar 08; 356(10):1009-19. PubMed ID: 17296822
    [Abstract] [Full Text] [Related]

  • 22. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A, Leon MB, Lansky AJ, Nikolsky E, Aoki J, Moses JW, Schofer J, Morice MC, Schampaert E, Kirtane AJ, Popma JJ, Parise H, Fahy M, Mehran R.
    J Am Coll Cardiol; 2009 Sep 01; 54(10):894-902. PubMed ID: 19712798
    [Abstract] [Full Text] [Related]

  • 23. Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions.
    Silber S, Colombo A, Banning AP, Hauptmann K, Drzewiecki J, Grube E, Dudek D, Baim DS.
    Circulation; 2009 Oct 13; 120(15):1498-504. PubMed ID: 19786634
    [Abstract] [Full Text] [Related]

  • 24. Direct stenting with TAXUS stents seems to be as safe and effective as with predilatation. A post hoc analysis of TAXUS II.
    Silber S, Hamburger J, Grube E, Pfisterer M, Belardi J, Webb J, Zmudka K, Nienaber C, Hauptman K, Rutsch W, Dawkins K, Drzewiecki J, Koglin J, Colombo A.
    Herz; 2004 Mar 13; 29(2):171-80. PubMed ID: 15057438
    [Abstract] [Full Text] [Related]

  • 25. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial.
    Tanabe K, Serruys PW, Degertekin M, Grube E, Guagliumi G, Urbaszek W, Bonnier J, Lablanche JM, Siminiak T, Nordrehaug J, Figulla H, Drzewiecki J, Banning A, Hauptmann K, Dudek D, Bruining N, Hamers R, Hoye A, Ligthart JM, Disco C, Koglin J, Russell ME, Colombo A, TAXUS II Study Group.
    Circulation; 2005 Feb 22; 111(7):900-5. PubMed ID: 15710761
    [Abstract] [Full Text] [Related]

  • 26. Overlapping paclitaxel-eluting stents: long-term effects in a porcine coronary artery model.
    Wilson GJ, Polovick JE, Huibregtse BA, Poff BC.
    Cardiovasc Res; 2007 Nov 01; 76(2):361-72. PubMed ID: 17716637
    [Abstract] [Full Text] [Related]

  • 27. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.
    Jiménez-Quevedo P, Sabaté M, Angiolillo DJ, Alfonso F, Hernández-Antolín R, SanMartín M, Gómez-Hospital JA, Bañuelos C, Escaned J, Moreno R, Fernández C, Fernández-Avilés F, Macaya C, DIABETES Investigators.
    Eur Heart J; 2007 Aug 01; 28(16):1946-52. PubMed ID: 17562666
    [Abstract] [Full Text] [Related]

  • 28. 2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry).
    Kaltoft A, Jensen LO, Maeng M, Tilsted HH, Thayssen P, Bøttcher M, Lassen JF, Krusell LR, Rasmussen K, Hansen KN, Pedersen L, Johnsen SP, Sørensen HT, Thuesen L.
    J Am Coll Cardiol; 2009 Feb 24; 53(8):658-64. PubMed ID: 19232897
    [Abstract] [Full Text] [Related]

  • 29. Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.
    Piscione F, Piccolo R, Cassese S, Galasso G, Chiariello M.
    Catheter Cardiovasc Interv; 2009 Aug 01; 74(2):323-32. PubMed ID: 19360858
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C, Kim SH, Suh J, Park DW, Lee SH, Kim YH, Hong MK, Kim JJ, Park SW, Park SJ.
    Catheter Cardiovasc Interv; 2008 Apr 01; 71(5):594-8. PubMed ID: 18311841
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial.
    Ellis SG, O'Shaughnessy CD, Martin SL, Kent K, McGarry T, Turco MA, Kereiakes DJ, Popma JJ, Friedman M, Koglin J, Stone GW, TAXUS V ISR Investigators.
    Eur Heart J; 2008 Jul 01; 29(13):1625-34. PubMed ID: 18556716
    [Abstract] [Full Text] [Related]

  • 36. Comparison of long-term outcomes of bare metal or drug-eluting stent implantation in standard versus off-label coronary narrowings.
    Harjai KJ, Orshaw P, Boura J, Sporn D.
    Am J Cardiol; 2009 Jun 01; 103(11):1537-45. PubMed ID: 19463512
    [Abstract] [Full Text] [Related]

  • 37. A more than 2-year follow-up of incomplete apposition after drug-eluting stent implantation.
    Qian JY, Zhang F, Fan B, Ge L, Wang QB, Ge JB.
    Chin Med J (Engl); 2008 Mar 20; 121(6):498-502. PubMed ID: 18364132
    [Abstract] [Full Text] [Related]

  • 38. [Stent thrombosis in the era of drug-eluting stents].
    Wöhrle J.
    Herz; 2007 Aug 20; 32(5):411-8. PubMed ID: 17687531
    [Abstract] [Full Text] [Related]

  • 39. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M, Patti G, D'Ambrosio A, Di Sciascio G.
    Catheter Cardiovasc Interv; 2008 Apr 01; 71(5):600-4. PubMed ID: 18360849
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.